The Role of Zamzam Water in Idiopathic Oligohydramnios

NCT ID: NCT04684680

Last Updated: 2021-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the efficacy of drinking zamzam water versus tap water in increasing the AF index in women with oligohydramnios.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Oligohydramnios refers to decrease in amniotic fluid and it is defined as a deepest fluid pocket of less than 2 cm or an amniotic fluid index of 5 cm or less. Oligohydramnios complicates 0.5% to 8% of pregnancies, and 12 % if postdates When it occurs in first half of pregnancy it is associated with birth defects while in second half it causes poor fetal growth, malpresentations , FHR decelerations , MAS , Fetal suicidal syndrome and increases cesarean section and management and prognosis depend on gestational age

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oligohydramnios

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

open label randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

open label randomized controlled trial

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

zamzam water

patient will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term

Group Type EXPERIMENTAL

zamzam water

Intervention Type DIETARY_SUPPLEMENT

will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term

tap water

will receive the normal need of daily requirement of water (2.5 liter) in form of tap water

Group Type ACTIVE_COMPARATOR

tap water

Intervention Type DIETARY_SUPPLEMENT

will receive the normal need of daily requirement of water (2.5 liter) in form of tap water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

zamzam water

will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term

Intervention Type DIETARY_SUPPLEMENT

tap water

will receive the normal need of daily requirement of water (2.5 liter) in form of tap water

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

study group Active Comparator

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant female with idiopathic oligohydramnios

Exclusion Criteria

* patients with medical disorder
* congenital anomalies
* premature rupture of membrane
* Patient refuse to participate
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aswan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

hany farouk

A Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

nahla w shady, md

Role: STUDY_CHAIR

Aswan universirty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aswan University Hospital

Aswān, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hany f Sallam, md

Role: CONTACT

+201022336052 ext. 002

nahla w shady, md

Role: CONTACT

+201022336052 ext. 002

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hany F Sallam, MD

Role: primary

0122336052 ext. 002

Nahla W Shady, MD

Role: backup

01092440504 ext. 002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

aswu/3oo/6/19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oral Fluid Volume Expansion
NCT01360333 COMPLETED NA
Fluid Administration in Ketoacidosis (DRINK)
NCT06541535 NOT_YET_RECRUITING PHASE4
Boluses of Ringer's in Surgical Kids (BRiSK Study)
NCT05285371 COMPLETED EARLY_PHASE1